List of Tables
Table 1. Global Postmenopausal Osteoporosis Drugs Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Postmenopausal Osteoporosis Drugs Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Postmenopausal Osteoporosis Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Postmenopausal Osteoporosis Drugs Covered in This Study
Table 5. Global Postmenopausal Osteoporosis Drugs Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Postmenopausal Osteoporosis Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Postmenopausal Osteoporosis Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Postmenopausal Osteoporosis Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Postmenopausal Osteoporosis Drugs Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Postmenopausal Osteoporosis Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Postmenopausal Osteoporosis Drugs Product Type
Table 12. Global Postmenopausal Osteoporosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Postmenopausal Osteoporosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Postmenopausal Osteoporosis Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Postmenopausal Osteoporosis Drugs Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Postmenopausal Osteoporosis Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Postmenopausal Osteoporosis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Postmenopausal Osteoporosis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Postmenopausal Osteoporosis Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Postmenopausal Osteoporosis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Postmenopausal Osteoporosis Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Postmenopausal Osteoporosis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Postmenopausal Osteoporosis Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Postmenopausal Osteoporosis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Postmenopausal Osteoporosis Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Postmenopausal Osteoporosis Drugs Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Postmenopausal Osteoporosis Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Postmenopausal Osteoporosis Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Postmenopausal Osteoporosis Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Postmenopausal Osteoporosis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Postmenopausal Osteoporosis Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Postmenopausal Osteoporosis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Postmenopausal Osteoporosis Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Postmenopausal Osteoporosis Drugs Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Postmenopausal Osteoporosis Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Postmenopausal Osteoporosis Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Postmenopausal Osteoporosis Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Postmenopausal Osteoporosis Drugs Sales (K Pcs) by Type (2016-2021)
Table 39. Global Postmenopausal Osteoporosis Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Postmenopausal Osteoporosis Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Postmenopausal Osteoporosis Drugs Revenue Share by Type (2016-2021)
Table 42. Global Postmenopausal Osteoporosis Drugs Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Postmenopausal Osteoporosis Drugs Sales (K Pcs) by Application (2016-2021)
Table 44. Global Postmenopausal Osteoporosis Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Postmenopausal Osteoporosis Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Postmenopausal Osteoporosis Drugs Revenue Share by Application (2016-2021)
Table 47. Global Postmenopausal Osteoporosis Drugs Price (USD/Pcs) by Application (2016-2021)
Table 48. Eli Lilly Corporation Information
Table 49. Eli Lilly Description and Business Overview
Table 50. Eli Lilly Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Eli Lilly Postmenopausal Osteoporosis Drugs Product
Table 52. Eli Lilly Recent Developments/Updates
Table 53. Amgen Corporation Information
Table 54. Amgen Description and Business Overview
Table 55. Amgen Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Amgen Postmenopausal Osteoporosis Drugs Product
Table 57. Amgen Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Merck Postmenopausal Osteoporosis Drugs Product
Table 62. Merck Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Novartis Postmenopausal Osteoporosis Drugs Product
Table 67. Novartis Recent Developments/Updates
Table 68. Allergan Corporation Information
Table 69. Allergan Description and Business Overview
Table 70. Allergan Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Allergan Postmenopausal Osteoporosis Drugs Product
Table 72. Allergan Recent Developments/Updates
Table 73. Amgen Astellas Biopharm Corporation Information
Table 74. Amgen Astellas Biopharm Description and Business Overview
Table 75. Amgen Astellas Biopharm Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Amgen Astellas Biopharm Postmenopausal Osteoporosis Drugs Product
Table 77. Amgen Astellas Biopharm Recent Developments/Updates
Table 78. Deltanoid Pharmaceuticals Corporation Information
Table 79. Deltanoid Pharmaceuticals Description and Business Overview
Table 80. Deltanoid Pharmaceuticals Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Deltanoid Pharmaceuticals Postmenopausal Osteoporosis Drugs Product
Table 82. Deltanoid Pharmaceuticals Recent Developments/Updates
Table 83. Noven Corporation Information
Table 84. Noven Description and Business Overview
Table 85. Noven Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Noven Postmenopausal Osteoporosis Drugs Product
Table 87. Noven Recent Developments/Updates
Table 88. Novo Nordisk Corporation Information
Table 89. Novo Nordisk Description and Business Overview
Table 90. Novo Nordisk Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Novo Nordisk Postmenopausal Osteoporosis Drugs Product
Table 92. Novo Nordisk Recent Developments/Updates
Table 93. Osteologix Corporation Information
Table 94. Osteologix Description and Business Overview
Table 95. Osteologix Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Osteologix Postmenopausal Osteoporosis Drugs Product
Table 97. Osteologix Recent Developments/Updates
Table 98. Pfizer Corporation Information
Table 99. Pfizer Description and Business Overview
Table 100. Pfizer Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Pfizer Postmenopausal Osteoporosis Drugs Product
Table 102. Pfizer Recent Developments/Updates
Table 103. PhytoHealth Corporation Information
Table 104. PhytoHealth Description and Business Overview
Table 105. PhytoHealth Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. PhytoHealth Postmenopausal Osteoporosis Drugs Product
Table 107. PhytoHealth Recent Developments/Updates
Table 108. Radius Health Corporation Information
Table 109. Radius Health Description and Business Overview
Table 110. Radius Health Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Radius Health Postmenopausal Osteoporosis Drugs Product
Table 112. Radius Health Recent Developments/Updates
Table 113. Tarsa Therapeutics Corporation Information
Table 114. Tarsa Therapeutics Description and Business Overview
Table 115. Tarsa Therapeutics Postmenopausal Osteoporosis Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Tarsa Therapeutics Postmenopausal Osteoporosis Drugs Product
Table 117. Tarsa Therapeutics Recent Developments/Updates
Table 118. Production Base and Market Concentration Rate of Raw Material
Table 119. Key Suppliers of Raw Materials
Table 120. Postmenopausal Osteoporosis Drugs Distributors List
Table 121. Postmenopausal Osteoporosis Drugs Customers List
Table 122. Postmenopausal Osteoporosis Drugs Market Trends
Table 123. Postmenopausal Osteoporosis Drugs Growth Drivers
Table 124. Postmenopausal Osteoporosis Drugs Market Restraints
Table 125. Global Postmenopausal Osteoporosis Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 126. Global Postmenopausal Osteoporosis Drugs Sales Market Share Forecast by Type (2022-2027)
Table 127. Global Postmenopausal Osteoporosis Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 128. Global Postmenopausal Osteoporosis Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 129. Global Postmenopausal Osteoporosis Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 130. Global Postmenopausal Osteoporosis Drugs Sales Market Share Forecast by Application (2022-2027)
Table 131. Global Postmenopausal Osteoporosis Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 132. Global Postmenopausal Osteoporosis Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 133. Global Postmenopausal Osteoporosis Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 134. Global Postmenopausal Osteoporosis Drugs Sales Market Share Forecast by Region (2022-2027)
Table 135. Global Postmenopausal Osteoporosis Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 136. Global Postmenopausal Osteoporosis Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Postmenopausal Osteoporosis Drugs
Figure 2. Global Postmenopausal Osteoporosis Drugs Market Share by Type in 2020 & 2027
Figure 3. Antiresorptive Medications Product Picture
Figure 4. Anabolic Medications Product Picture
Figure 5. Global Postmenopausal Osteoporosis Drugs Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Other
Figure 9. Global Postmenopausal Osteoporosis Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Postmenopausal Osteoporosis Drugs Market Size 2016-2027 (US$ Million)
Figure 11. Global Postmenopausal Osteoporosis Drugs Sales 2016-2027 (K Pcs)
Figure 12. Global Postmenopausal Osteoporosis Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Postmenopausal Osteoporosis Drugs Sales Share by Manufacturers in 2020
Figure 14. Global Postmenopausal Osteoporosis Drugs Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Postmenopausal Osteoporosis Drugs Players: Market Share by Revenue in 2020
Figure 16. Postmenopausal Osteoporosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Postmenopausal Osteoporosis Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Postmenopausal Osteoporosis Drugs Sales Market Share by Region in 2020
Figure 19. Global Postmenopausal Osteoporosis Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Postmenopausal Osteoporosis Drugs Revenue Market Share by Region in 2020
Figure 21. U.S. Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. U.A.E Postmenopausal Osteoporosis Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Postmenopausal Osteoporosis Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Postmenopausal Osteoporosis Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Postmenopausal Osteoporosis Drugs by Application in 2020
Figure 48. Revenue Share of Postmenopausal Osteoporosis Drugs by Application (2016-2021)
Figure 49. Revenue Share of Postmenopausal Osteoporosis Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Postmenopausal Osteoporosis Drugs
Figure 51. Manufacturing Process Analysis of Postmenopausal Osteoporosis Drugs
Figure 52. Postmenopausal Osteoporosis Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

LIST OF FIGURE